Literature DB >> 8167344

Monocyte dysfunction in patients with Gaucher disease: evidence for interference of glucocerebroside with superoxide generation.

Y Liel1, A Rudich, O Nagauker-Shriker, T Yermiyahu, R Levy.   

Abstract

Gaucher disease patients are occasionally affected by chronic or fulminant infections. Since Gaucher cells originate from tissue phagocytes, we studied the functional implications of glucocerbroside accumulation on phagocytes in Gaucher disease patients. Circulating monocytes and granulocytes from nine type I Gaucher disease patients, and matched controls, were studied. Evaluation of phagocytic activity included (1) maximal superoxide generation rates following stimulation by phorbol 12-myristate 13-acetate (PMA), opsonized zymosan (OZ), or formyl-methionyl-leucylphenylalanine (FMLP); (2) nitroblue tetrazolium reduction test (NBT); (3) chemotaxis toward FMLP; (4) phagocytosis of OZ particles; and (5) killing activity against Staphylococcus aureus. Superoxide generation in monocytes following PMA, OZ, and FMLP stimulation was significantly suppressed at 52% +/- 15%, 39% +/- 8%, and 51% +/- 11% of control, respectively. Superoxide generation in granulocytes was normal. NBT reduction, staphylococcal killing, and phagocytosis were also markedly decreased in monocytes, and normal in granulocytes. Mean chemotaxis rates were normal in both monocytes and granulocytes; however, decreased chemotactic rates were observed in some patients. The abnormality of superoxide generation could be reproduced in a dose- and time-dependent manner in normal circulating monocytes incubated with glucocerebroside. Superoxide generation in glucocerebroside-conditioned normal monocytes in a cell-free system showed normal superoxide generation, reflecting the integrity of the NADPH oxidase complex itself. These results demonstrate markedly compromised phagocytic functions in circulating monocytes in Gaucher disease patients. These abnormalities can be attributed to accumulation of glucocerebroside, since it could be reproduced in normal monocytes incubated with glucocerebroside. Similar abnormalities in Gaucher cells throughout the reticuloendothelial system could impair host defense, and may be of particular importance in the pathogenesis of osteomyelitis in Gaucher disease patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8167344

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  Gaucher disease gene GBA functions in immune regulation.

Authors:  Jun Liu; Stephanie Halene; Mei Yang; Jameel Iqbal; Ruhua Yang; Wajahat Z Mehal; Wei-Lien Chuang; Dhanpat Jain; Tony Yuen; Li Sun; Mone Zaidi; Pramod K Mistry
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-04       Impact factor: 11.205

2.  Mechanisms of Gaucher disease pathogenesis.

Authors:  Simon Wheeler; Dan John Sillence
Journal:  Ann Transl Med       Date:  2015-05

3.  Sphingolipids and Redox Signaling in Renal Regulation and Chronic Kidney Diseases.

Authors:  Owais M Bhat; Xinxu Yuan; Guangbi Li; RaMi Lee; Pin-Lan Li
Journal:  Antioxid Redox Signal       Date:  2018-01-09       Impact factor: 8.401

4.  The MAPK ERK5, but not ERK1/2, inhibits the progression of monocytic phenotype to the functioning macrophage.

Authors:  Xuening Wang; Stella Pesakhov; Jonathan S Harrison; Michael Kafka; Michael Danilenko; George P Studzinski
Journal:  Exp Cell Res       Date:  2014-10-16       Impact factor: 3.905

5.  Inhibition of NADPH oxidase by glucosylceramide confers chemoresistance.

Authors:  Brian M Barth; Sally J Gustafson; Megan M Young; Todd E Fox; Sriram S Shanmugavelandy; James M Kaiser; Myles C Cabot; Mark Kester; Thomas B Kuhn
Journal:  Cancer Biol Ther       Date:  2010-12-01       Impact factor: 4.742

6.  The effects of Bruton tyrosine kinase inhibition on chemotaxis and superoxide generation in human neutrophils.

Authors:  Arnon Broides; Nurit Hadad; Jacov Levy; Rachel Levy
Journal:  J Clin Immunol       Date:  2014-04-26       Impact factor: 8.317

7.  Stimulation of innate immunity by susceptible and multidrug-resistant Pseudomonas aeruginosa: an in vitro and in vivo study.

Authors:  E J Giamarellos-Bourboulis; D Plachouras; A Tzivra; V Kousoulas; N Bolanos; M Raftogiannis; I Galani; I Dontas; A Dionyssiou-Asteriou; H Giamarellou
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

8.  Effective immunomodulatory treatment of Escherichia coli experimental sepsis with thalidomide.

Authors:  Evangelos J Giamarellos-Bourboulis; Helen Poulaki; Nikolaos Kostomitsopoulos; Ismene Dontas; Despina Perrea; Panayotis E Karayannacos; Helen Giamarellou
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

9.  Direct effect of human immunodeficiency virus protease inhibitors on neutrophil function and apoptosis via calpain inhibition.

Authors:  Nurit Hadad; Rachel Levy; Francisc Schlaeffer; Klaris Riesenberg
Journal:  Clin Vaccine Immunol       Date:  2007-09-12

Review 10.  Pathogen destruction versus intracellular survival: the role of lipids as phagosomal fate determinants.

Authors:  Benjamin E Steinberg; Sergio Grinstein
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.